Amy McCormick
Pediatrics · Davenport, IANPI 1275874273
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,562, more than ten times the $64 reported in 2022. Among pediatrics clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$459
- Otsuka America Pharmaceutical, Inc.$396
- Axsome Therapeutics, Inc.$241
- TG Therapeutics, Inc.$238
- Neurocrine Biosciences, Inc.$230
- Teva Pharmaceuticals USA, Inc.$228
- plus $943 from 14 others
What the payments were for
- Food & beverage$2,736100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,736 in reported general payments places this provider in the 95th percentile of 308 pediatrics providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 21 | $9,510 |
| Lurasidone Hcl | 17 | $4,774 |
| Ziprasidone Hcl | 13 | $1,090 |
| Clozapine | 16 | $1,044 |
| Fluoxetine Hcl | 48 | $1,002 |
| Hydroxyzine Hcl | 37 | $905 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 29 | $904 |
| Quetiapine Fumarate | 37 | $749 |
| Divalproex Sodium ErDivalproex Sodium | 15 | $694 |
| Clonazepam | 36 | $526 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $518 |
| Olanzapine | 11 | $503 |
| Lorazepam | 57 | $463 |
| Mirtazapine | 14 | $458 |
| Trazodone Hcl | 37 | $410 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Davenport
- Barbara HarreDavenport$2K
- Richard BlunkDavenport$2K
- Nazir KayaliDavenport$1K
- Janessa MontgomeryDavenport$939
- Ezekiel HartmanDavenport$805
- Daniel SleiterDes Moines$44K
- Lauren Siebrase WilkesIowa City$33K
- Heidi KochDes Moines$16K
- Jan FooteDes Moines$9K
- Laura DenningCouncil Bluffs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.